A seasoned litigator, Laura Mummert leads the firm’s Antitrust department. For more than two decades, Laura has built a legal career advising participants in the healthcare, pharmaceuticals, automotive, entertainment, and other highly regulated industries. Her extensive experience includes disputes involving recovery of overcharges from unlawful pricing practices, market allocations, and pay-for-delay schemes. In recent years, much of her practice has been concentrated on representing major health insurers in complex, high-stakes cost-recovery litigation. Notably, she was a lead member of the litigation teams prosecuting claims on behalf of several health insurers in In re Generic Pharmaceuticals Pricing Antitrust Litigation, MDL (E.D. Pa.) and Blue Cross Blue Shield Ass’n, et al. v GlaxoSmithKline LLC, No. 12-4663-JS (E.D. Pa).
Committed to developing productive, ongoing relationships with clients, Laura also provides broad-ranging guidance on issues such as the merits of class action claims and strategic considerations in pursuing a recovery in such matters, as well as settlement negotiations. She is adept at in-depth legal analyses, investigation, and identification of critical evidence that informs her formulation of strategies to maximize client recoveries.
Among numerous other matters, Laura has prosecuted large-scale securities, antitrust, and consumer fraud cases. Laura was part of the lead counsel team in In re Aftermarket Automotive Sheet Metal Indirect Purchaser Litigation, which led to a $9.85 million recovery, and participated on the litigation teams prosecuting several other antitrust class actions, including In re Disposable Contact Lens Antitrust Litigation, and In re Dental Supplies Antitrust Litigation.
Laura also served as part of the teams that prosecuted In re General Motors Corp. Securities Litigation, which settled for $300 million, In re Oppenheimer Champion Fund Securities Litigation and In re Oppenheimer Core Bond Fund Securities Litigation, both of which settled for a combined $100 million after successfully opposing the defendants’ request for dismissal, and In re Take-Two Interactive Securities Litigation where investors achieved a $20.1 million settlement. Laura also played a significant role in the prosecution of In re Amgen Inc. Securities Litigation, which settled for $95 million and resulted in the landmark U.S. Supreme Court decision, Amgen Inc. v. Conn. Ret. Plans & Tr. Funds, 568 U.S. 455 (2013).
She served as one of the lead attorneys who obtained class certification of a nationwide class against Avis Rent-A-Car Systems, LLC, and Budget Rent-A-Car Systems, Inc., for allegedly charging customers a deceptive fee for earning frequent flyer miles in connection with their car rentals, a case that resulted in a $13.7 million recovery for the class. Laura also served on the litigation team in a breach of fiduciary duty action against the Board of Pensions for one of the largest Christian denominations in the United States and obtained a full recovery for each of the plaintiffs.
She also served on the litigation team that prosecuted the data breach action against Target after hackers stole the personal and financial information of up to 110 million Target customers during the height of the 2013 holiday season, and the team that brought the concussive injury case against the National Hockey League for its failure to disclose to its players the long-term risk of neurodegenerative disorders and diseases involved with repeated head traumas that have become inherent to the league.
